Expert Statement: David McErlane and Aris Gennadios, Catalent
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Chemistry
Expert Statement: Ashu Tandon, Aragen
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Neil Jones, Aenova
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Tom Sellig, Adare Pharma Solutions
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
Expert Statement: Gavin Murdoch, Abzena
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.
The Evolution of the CDMO Industry.
The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine. CHEManager asked executives and industry experts from a broad range of CDMOs to share their views on how their companies are dealing with this changing economic environment and the resulting opportunities and challenges.
Sustainable Practices in Biopharmaceuticals
BioPhorum, an industry collaboration group, focuses on advancing sustainability within the biopharmaceutical sector. In an exclusive interview, Nicola Coles, Director of BioPhorum Sustainability, shares insights into the organization’s commitment to environmentally responsible practices.
Sustainability from the Beginning
The idea that statistics can address urgent sustainability concerns at the lab bench was central to presentations at the recent JMP Discovery Summit Europe in Manchester, UK.
Securing Supply Chains and Strengthening Partnerships
Interview with Edgardo Hernandez, President Manufacturing, Lilly
Integrated Continuous Manufacturing in Pharmaceuticals
An innovative manufacturing platform called integrated continuous manufacturing (ICM) represents a completely modernized model for drug manufacturing. In contrast to batch processes, ICM’s unique operational advantages will allow for cost-competitive end-to-end manufacturing and enable a more robust and responsive supply chain for critical drugs.
A New Standard of Collaboration for the Pharmaceutical Industry
Headquartered in Cramlington, UK, Sterling Pharma Solutions is a contract development and manufacturing organization (CDMO) that provides a range of services to the global biopharmaceutical industry, including active pharmaceutical ingredient (API) development, scale-up and cGMP manufacturing, as well as antibody drug conjugate (ADC) R&D and clinical-scale GMP manufacturing.
The Future of mRNA Technology
mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its potential. Experts see a wide range of potential applications for this relatively new technology, particularly in infectious diseases and cancer.
AI-Powered Knowledge Transfer in Manufacturing
Artificial intelligence (AI) can help companies in the process industry capture, retain and access valuable historical expertise and ease the transition for new colleagues in the plant.
Unleashing Sustainable Innovation, Navigating Business, and Pioneering a Greener Future
In today’s world, where environmental sustainability is at the forefront of global concerns, green chemistry stands as a beacon of hope. This field focuses on inventing sustainable solutions that mitigate the harmful impact of traditional chemical processes.
The Green Power of Catalysis
With more than 80% of all chemical products manufactured using catalytic processes, catalysts are the number one value generator in the chemical industry.
Packaging Industry Drives Circular Economy through Science, Innovation and Consumer Insights
The concept of a circular economy, where materials are recycled and reused, is becoming increasingly important in consumer packaging, driven by regulatory requirements and customer interest. Modern technical advancements make it easier to think of today's goods and products as the resources of tomorrow. One such product is plastic.
Spray Drying for Inhalation: the Challenges of Scale-up
When developing an inhaled powder formulation, the drug particles’ properties are critical to successful delivery to the deep lung. The aerodynamic diameter is the key parameter, as it represents how well the particle flies in an air stream.
The Use of Evonik’s Catalysts to Manufacture TFA-free Margarines
When manufacturing specialty edible fats, ensuring that the product has the desired properties – such as a stable shelf life, optimal melting behavior, and texture – is essential.
Providing Solutions by Making the Most of Biomedical Data
Many life science companies generate large swathes of data.
How CDMOs Can Contribute to Pharma Supply even Better
The demand for medicines is increasing rapidly and R&D pipelines have doubled over the last decade.
Johnson Matthey Set to Catalyze the Net Zero Transition
Johnson Matthey (JM) looks back at a legacy of 200+ years. Established in 1817, the London, England-based chemical company reported annual revenues of about €18 billion in 2022. JM has built a global presence with operations in more than 30 countries. The company’s strategy is based on the vision for a cleaner, healthier world and mirrors society’s need to create a more sustainable future. JM has set out to catalyze the net zero transition by delivering sustainable solutions to customers enabled by innovative technology and leading positions in JM’s key markets automotive, chemicals, and energy. To get a better understanding of the role JM’s technological developments play for a sustainable future, Michael Reubold spoke with Maurits van Tol, the company’s Chief Technology Officer.
Small Particles with a Big Impact
In 2022, the European Commission revised the definition of nanomaterials in a new recommendation, which supports a uniform EU regulatory framework and aims at aligning the legislation across various sectors. Therefore, particle product design is an enabling technology relevant for many sectors, such as chemicals, consumer products, foods and beverages, health, energy, and the environment.
Rewriting the Rules for Chemical Distribution
Having survived the pandemic so far in good condition, chemical distributors are well positioned to grow, provided they understand how the rules for winning have changed. Distributors that keep their customers’ needs front and center will be best positioned to succeed, regardless of what the future brings.
Investing in Growth Through Innovation
Interview with Marc Doyle, CEO of Arxada, which was created following the carve-out and sale of Lonza Specialty Ingredients to private equity firms Bain Capital and Cinven.
Ensuring API Supply Capacities for Europe and Beyond
Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.
Proactive Supplier Risk Mitigation for Manufacturing and Testing Organizations
There is a new urgency in the market for manufacturers and testing organizations to be prepared for rapid, unexpected changes in material resource access, exacerbated by turbulent regional and global events. This focus is in addition to reinforcing routine risk mitigation activities around the raw material supply chain, adding to the relevance and impact of the topic.
Planning for the Unexpected
Dorothee Arns, Director General of FECC, discusses current challenges, market trends and her vision for the chemical distribution industry in Europe. The interview was conducted by Michael Reubold and Ralf Kempf.
Expert Statement: Andreas Woschek, Executive Vice President Chemicals, Helm
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Patrick Barthels, CSO and Hartmut Kunz, CFO, Oqema
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Gerd Bergmann, Chairman of the Managing Board, Nordmann
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Integrated Drug Development Models
Interview with Giovanna Libralon, Senior Director Commercial Development Small Molecules at Lonza.
Expert Statement: Thomas Dassler, Managing Director, Häffner
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Christopher Erbslöh, Managing Director, C.H. Erbslöh
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
Expert Statement: Neville Prior, Group Chairman, Cornelius Group
CHEManager asked executives and industry experts to share their views on the prospects for the chemical distribution sector.
